Nebivololo Zentiva (Nebivolol Hydrochloride)

Nebivololo Zentiva is a beta‑blocker that acts on the cardiovascular system to control blood pressure and support cardiac function.

• Essential hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk.
• Heart failure (when indicated): improves ventricular filling and reduces symptoms of congestion.

• Nebivolol Hydrochloride selectively antagonizes β1‑adrenergic receptors, decreasing heart rate and myocardial contractility, which reduces cardiac output and blood pressure. In addition, it stimulates endothelial nitric‑oxide synthase, causing nitric‑oxide mediated vasodilation that further contributes to blood pressure reduction without significant β2 blockade.

Nebivololo Zentiva may cause a range of adverse reactions.

Common Side Effects

• Headache: mild to moderate discomfort often occurring early in therapy.
• Dizziness or light‑headedness: related to blood pressure lowering.
• Fatigue or tiredness: reduced cardiac workload may cause transient tiredness.
• Nasal congestion: mild upper‑respiratory irritation.
• Bradycardia: slower heart rate, usually asymptomatic.

Serious or Rare Side Effects

• Severe bradycardia: markedly low heart rate requiring medical attention.
• Symptomatic hypotension: significant drop in blood pressure causing fainting.
• Bronchospasm: especially in patients with reactive airway disease.
• Allergic reactions: rash, itching, or anaphylaxis in rare cases.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

• Blood pressure monitoring: ensure adequate control and avoid excessive hypotension.
• Cardiac function assessment: evaluate for underlying conduction abnormalities.
• Asthma or COPD caution: β1‑selectivity reduces but does not eliminate risk of bronchospasm.
• Avoid abrupt discontinuation: taper dose to prevent rebound hypertension.
• Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nebivololo Zentiva can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Concomitant use with other β‑blockers: may cause additive bradycardia and hypotension.
• Calcium‑channel blockers (verapamil, diltiazem): increase plasma levels and risk of cardiac depression.
• Potent CYP2D6 inhibitors (paroxetine, fluoxetine): raise nebivolol concentrations.

Moderate Interactions (Monitor Closely)

• NSAIDs: may attenuate antihypertensive effect.
• Diuretics: combined effect may lead to excessive blood pressure reduction.
• Clonidine: abrupt withdrawal can cause rebound hypertension; monitor when combined.